Sales of New 'High-End' qPCR System Help Offset Flat Q3 Revenues for Life Tech's Molecular Bio Business
October 28, 2010
Sales of New 'High-End' qPCR System Help Offset Flat Q3 Revenues for Life Tech's Molecular Bio Business
Life Tech executives said that the new qPCR instrument platform, called the ViiA 7, is just one of several innovations planned over the next several months to overhaul its qPCR business, and that its recent acquisitions in the digital and high-throughput PCR space would play a large part in that overhaul.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Life Tech Banks on qPCR to Stimulate Growth of Lackluster Molecular Biology Business
October 27, 2011 / PCR Insider - Life Tech Temporarily Stems qPCR Royalty Decline in Q3
November 8, 2012 / PCR Insider - Life Tech Genetic Analysis Revenues Decline as qPCR Royalties Wither, Though QuantStudio Sales Spike
August 2, 2012 / PCR Insider - DiaGenic-GE Pact Aims for MDx Test to ID Alzheimer's Risk Patients for Follow-up PET Imaging
March 29, 2012 / PCR Insider - Life Tech Says qPCR Consumables, Applied Testing Strong Despite Q2 Drop in Division Revenues
August 4, 2011 / PCR Insider